These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


669 related items for PubMed ID: 6821161

  • 1. Diagnosis, prevention, and therapy in hemolytic disease of the newborn.
    Polesky HF.
    Clin Lab Med; 1982 Mar; 2(1):107-22. PubMed ID: 6821161
    [No Abstract] [Full Text] [Related]

  • 2. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV, Beck ML.
    Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
    [No Abstract] [Full Text] [Related]

  • 3. [Prevention of fetal erythroblastosis with anti-D immunoglobulin].
    Rasteński J, Gryglicka M.
    Acta Haematol Pol; 1988 Feb; 19(3-4):239-41. PubMed ID: 3150900
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Mechanism of action of anti-D-gamma globulin in preventing rhesus alloimmunization in the pregnant woman and hemolytic disease of the newborn infant].
    Vŭlcheva B, Spasova K.
    Akush Ginekol (Sofiia); 1985 Feb; 24(2):73-6. PubMed ID: 2990248
    [No Abstract] [Full Text] [Related]

  • 9. [Allo-immunization. 2: Its treatment and prevention].
    Bowman J, Lorrain J.
    Union Med Can; 1984 Apr; 113(4):312-9. PubMed ID: 6428021
    [No Abstract] [Full Text] [Related]

  • 10. [Our experience with the pre- and postnatal diagnosis of ABO-hemolytic disease of the newborn].
    Novachev D, Markov L, Antonov L, Tankov Ts.
    Akush Ginekol (Sofiia); 1977 Apr; 16(5):317-26. PubMed ID: 413455
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Prevention, diagnosis and therapy of Rh incompability].
    Wilken VH.
    Zentralbl Gynakol; 1975 Apr; 97(14):833-45. PubMed ID: 814741
    [Abstract] [Full Text] [Related]

  • 16. [Actual possibilities of prevention of serologic incompatibility].
    Breborowicz H, Gerwelowa H, Krawczyńska Z, Baraniecka K, Gruszczyńska J, Karowa L.
    Pol Tyg Lek; 1968 Sep 26; 23(35):1305-7. PubMed ID: 4972438
    [No Abstract] [Full Text] [Related]

  • 17. Erythroblastosis fetalis: identification, management, and prevention.
    Frigoletto FD, Umansky I.
    Clin Perinatol; 1979 Sep 26; 6(2):321-30. PubMed ID: 117965
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Prevention of hemolytic disease of the newborn using anti-rhesus (D) gamma globulin].
    Borst-Eilers E.
    Maandschr Kindergeneeskd; 1969 Dec 26; 37(7):243-51. PubMed ID: 4188422
    [No Abstract] [Full Text] [Related]

  • 20. [Discontinuing serological tests for anti-A and anti-B antibodies in pregnant women].
    Orv Hetil; 1984 Aug 26; 125(35):2137. PubMed ID: 6435052
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 34.